EuroEyes International Eye Clinic Limited (HK:1846)
:1846
Want to see HK:1846 full AI Analyst Report?
1846 Stock Chart & Stats
HK$3.00
-HK$0.02(-0.53%)
At close: 4:00 PM EST
HK$3.00
-HK$0.02(-0.53%)
Day’s Range― - ―
52-Week RangeHK$2.30 - HK$3.46
Previous CloseN/A
Volume15.00K
Average Volume (3M)156.72K
Market Cap
HK$757.86M
Enterprise ValueHK$470.71M
Total Cash (Recent Filing)HK$696.70M
Total Debt (Recent Filing)HK$410.19M
Price to Earnings (P/E)13.9
Beta0.18
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.99%
Share Statistics
EPS (TTM)0.17
Shares Outstanding320,706,000
10 Day Avg. Volume164,000
30 Day Avg. Volume156,720
Financial Highlights & Ratios
PEG Ratio-0.56
Price to Book (P/B)0.78
Price to Sales (P/S)1.22
P/FCF Ratio6.56
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Cash GenerationConsistent operating cash flow and rising free cash flow indicate durable internal funding for clinic operations, capex and dividends. This cash conversion cushions the business through profit volatility, supports reinvestment in clinics and funds debt servicing without relying on external capital.
Balance-sheet ResilienceA sizable equity base provides a meaningful capital cushion against shocks and supports credit capacity for expansion. Strong equity relative to assets enables strategic investments in new clinics or equipment while maintaining financial flexibility over the medium term.
Top-line RecoveryResumption of revenue growth demonstrates recovering patient volumes or pricing traction in elective eye-care. For a clinic-driven model, renewed top-line expansion is a structural positive, increasing potential scale benefits and providing a platform to restore margins if cost controls follow.
Bears Say
Profitability DeclineA sharp drop in net income despite revenue growth signals margin pressure or rising operating costs. Sustained earnings weakness erodes retained earnings, limits reinvestment and shareholder returns, and raises questions about efficiency in clinic operations or pricing sustainability.
Weakened Returns On EquityDeclining ROE points to materially lower capital efficiency, reducing long-term returns to shareholders. This trend can persist if profitability remains depressed or equity base grows faster than earnings, weakening the investment case for placing new capital into the business.
Rising Debt LevelThe jump in absolute debt raises interest and refinancing risk and narrows financial flexibility. Even with a solid equity cushion, higher leverage can constrain capital allocation, increase fixed costs, and amplify downside in an earnings downturn, making debt trends a structural watch item.
EuroEyes International Eye Clinic Limited News
1846 FAQ
What was EuroEyes International Eye Clinic Limited’s price range in the past 12 months?
EuroEyes International Eye Clinic Limited lowest stock price was HK$2.30 and its highest was HK$3.46 in the past 12 months.
What is EuroEyes International Eye Clinic Limited’s market cap?
EuroEyes International Eye Clinic Limited’s market cap is HK$757.86M.
When is EuroEyes International Eye Clinic Limited’s upcoming earnings report date?
EuroEyes International Eye Clinic Limited’s upcoming earnings report date is Aug 27, 2026 which is in 70 days.
How were EuroEyes International Eye Clinic Limited’s earnings last quarter?
EuroEyes International Eye Clinic Limited released its earnings results on Mar 31, 2026. The company reported HK$0.05 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.05.
Is EuroEyes International Eye Clinic Limited overvalued?
According to Wall Street analysts EuroEyes International Eye Clinic Limited’s price is currently Overvalued.
Does EuroEyes International Eye Clinic Limited pay dividends?
EuroEyes International Eye Clinic Limited pays a Quarterly dividend of HK$0.013 which represents an annual dividend yield of 1.99%. See more information on EuroEyes International Eye Clinic Limited dividends here
What is EuroEyes International Eye Clinic Limited’s EPS estimate?
EuroEyes International Eye Clinic Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does EuroEyes International Eye Clinic Limited have?
EuroEyes International Eye Clinic Limited has 320,706,000 shares outstanding.
What happened to EuroEyes International Eye Clinic Limited’s price movement after its last earnings report?
EuroEyes International Eye Clinic Limited reported an EPS of HK$0.05 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.372%.
Which hedge fund is a major shareholder of EuroEyes International Eye Clinic Limited?
Currently, no hedge funds are holding shares in HK:1846
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
EuroEyes International Eye Clinic Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-32.87%
12-Months-Change
Fundamentals
Return on Equity
4.33%
Trailing 12-Months
Asset Growth
22.06%
Trailing 12-Months
Company Description
EuroEyes International Eye Clinic Limited
EuroEyes International Eye Clinic Limited provides comprehensive vision correction services across Germany, Denmark, and the People's Republic of China. Their extensive array of procedures encompasses advanced refractive laser surgeries, such as ReLEx SMILE and FemtoLASIK, alongside phakic lens (ICL) implantation. They also perform various lens exchange surgeries, including both monofocal and trifocal options, in addition to offering PRK/LASEK and ICRS implantation services. These treatments are designed to address a spectrum of eye conditions, including myopia (nearsightedness), high myopia, presbyopia (age-related farsightedness), and cataracts. EuroEyes caters to a clientele predominantly in the mid-to-high income bracket. This demographic typically includes younger individuals seeking surgical solutions for myopia, as well as those aged 45 and older primarily requiring treatment for presbyopia or cataracts. The company manages a network of consultation centers, specialized eye treatment clinics, and dedicated LASIK centers. Furthermore, it engages in the sale of pharmaceutical products. Beyond direct patient care, EuroEyes diversifies its operations through the trading of eye clinic equipment and lenses, alongside ophthalmic equipment rental and managing operational spaces. Established in 1993, EuroEyes International Eye Clinic Limited maintains its headquarters in Hamburg, Germany.
Technical Analysis
Chaoju Eye Care Holdings Ltd.
―
C-MER Eye Care Holdings Limited
―
Hospital Corporation of China Ltd
―
Town Health International Medical Group Ltd.
―
UMP Healthcare Holdings Limited
―
Options Prices
Currently, No data available
---